A Steroid Receptor Coactivator Stimulator (MCB-613) Attenuates Adverse Remodeling After Myocardial Infarction
A steroid receptor coactivator stimulator (MCB-613) attenuates adverse remodeling after myocardial infarction Lisa K. Mullanya,1, Aarti D. Rohiraa,1, John P. Leachb,2, Jong H. Kimc,d,2, Tanner O. Monroec, Andrea R. Ortiza, Brittany Storka, M. Waleed Gabere, Poonam Sarkare, Andrew G. Sikoraf, Todd K. Rosengartg, Brian Yorka, Yongcheng Songh, Clifford C. Dacsoa, David M. Lonarda, James F. Martinc,d,3, and Bert W. O’Malleya,3 aDepartment of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX 77030; bPenn Cardiovascular Institute, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104; cDepartment of Molecular Physiology and Biophysics, Baylor College of Medicine, TX 77030; dCardiomyocyte Renewal Lab, Texas Heart Institute, Houston, TX 77030; eDepartment of Pediatrics, Baylor College of Medicine, Houston, TX 77030; fDepartment of Otolaryngology-Head & Neck Surgery, Baylor College of Medicine, Houston, TX 77030; gDepartment of Surgery, Baylor College of Medicine, Houston, TX 77030; and hDepartment of Pharmacology and Chemical Biology, Baylor College of Medicine, Houston, TX 77030 Contributed by Bert W. O’Malley, September 16, 2020 (sent for review June 23, 2020; reviewed by Chris Glass and Philip W. Shaul) Progressive remodeling of the heart, resulting in cardiomyocyte maintenance of metabolic regulation in diverse organ systems (CM) loss and increased inflammation, fibrosis, and a progressive including the heart (16). Specifically in the heart, recent findings decrease in cardiac function, are hallmarks of myocardial infarction indicate that SRC family members regulate cardiomyocyte func- (MI)-induced heart failure. We show that MCB-613, a potent small tion during early cardiac development (17) and in response to molecule stimulator of steroid receptor coactivators (SRCs) atten- cardiac metabolic stress (18).
[Show full text]